Sex-Steroid Imbalance in Females and Dry Eye
- 7 October 2014
- journal article
- review article
- Published by Taylor & Francis Ltd in Current Eye Research
- Vol. 40 (2), 162-175
- https://doi.org/10.3109/02713683.2014.966847
Abstract
Dry eye (DE) is a multifactorial disorder of the ocular surface unit that results in eye discomfort, visual disturbance and ocular surface damage. It is one of the most common complaints in daily ophthalmic practice. The risk of DE increases with age in both sexes, while its incidence is higher among females. In addition, the condition of menopause in aging women may also contribute to DE onset or worsening as a consequence of an overall hormonal imbalance. Sex hormones play a key role in ocular surface physiology and they impact differently on ocular surface tissues. Reduced estrogen levels were historically thought to be responsible in age-related DE onset but more recent investigations have reconsidered the role of androgens that are present and exert a protective function on the ocular surface. Hormone levels themselves, withdrawal changes in hormone levels, and the changes in hormone-receptor responsiveness are all important factors but it remains to be fully elucidated how estrogen or androgen insufficiency act alone or together in a combined imbalance or interplay to raise the risk of disease. The purpose of this review is to briefly outline current scientific evidence on the influence of androgens and estrogens, on the Lachrymal and Meibomian glands and on ocular surface epithelia including conjunctival goblet cells during reproductive and menopausal periods. The role of sex steroids is also discussed in relation to the pathogenesis of different forms of DE and Sjogren's syndrome (SS). The impact of systemic hormone therapy (HT) in DE post-menopausal women still appears as a controversial issue, despite the many clinical studies. Finally, the outcomes of topical applications of steroid-based products are summarized, underlying the need for potential (tear) biomarker(s) in the rationale of DE-targeted therapy.Keywords
This publication has 100 references indexed in Scilit:
- Hormones and dry eye syndromeCurrent Opinion in Opthalmology, 2013
- Towards a dynamic customised therapy for ocular surface dysfunctionsBritish Journal of Ophthalmology, 2013
- Gender, sex steroid hormones, and Alzheimer's diseaseHormones and Behavior, 2013
- Classification criteria for Sjögren's syndrome: we actually need to definitively resolve the long debate on the issueAnnals Of The Rheumatic Diseases, 2012
- Influence of sex hormones and genetic predisposition in Sjögren’s syndrome: A new clue to the immunopathogenesis of dry eye diseaseExperimental Eye Research, 2012
- Reproductive Hormones and the Menopause TransitionObstetrics and Gynecology Clinics of North America, 2011
- The G-protein-coupled estrogen receptor GPER in health and diseaseNature Reviews Endocrinology, 2011
- The reproductive endocrinology of the menopausal transitionSteroids, 2011
- The relationship between clinical signs and dry eye symptomsEye, 2011
- The Ocular Surface: The Challenge to Enable and Protect VisionInvestigative Ophthalmology & Visual Science, 2007